Home
Conditions
Malaria, Falciparum

Clinical trial condition

Malaria, Falciparum

Explore clinical trials studying Malaria, Falciparum. Study availability and eligibility vary by location and protocol.

368 public trials 16 recruiting studies

Refine in advanced search Browse all conditions

Malaria, Falciparum trial results

Completed

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

NCT00371735

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: GSK Investigational Site Ouagadougou, Burkina Faso

GSK Investigational Site Kumasi, Ghana

GSK Investigational Site Bamako, Mali

GSK Investigational Site Ile-Ife, Nigeria

View Trial Details

Completed

Chlorproguanil-Dapsone-Artesunate Versus COARTEM For Uncomplicated Malaria

NCT00344006

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: GSK Investigational Site Bobo-Dioulasso, Burkina Faso

GSK Investigational Site Kintampo, Ghana

GSK Investigational Site Eldoret, Kenya

GSK Investigational Site Kilifi, Kenya

View Trial Details

Completed

A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Malaria

NCT01992900

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Centre Muraz Bobo-Dioulasso, Burkina Faso

Centre National de Recherche et de Formation en Paludisme Ouagadougou, Burkina Faso

Kinshasa School of Public Health, School of Medicine, University of Kinshasa Kinshasa, Democratic Republic of the Congo

Manica's Health Research Centre Manica, Mozambique

View Trial Details

Completed

Community-based Screening and Treatment of Malaria in Pregnancy: a Cluster-randomized Trial

NCT01941264

Conditions: Infections, Malaria, Malaria, Antepartum, +7 more
Locations: Centre de Recherches Entomologiques de Cotonou (CREC) Cotonou, Benin

Clinical Research Unit of Nanoro URCN/CMA, Centre Muraz (CM) Nanoro, Burkina Faso

Medical Research Council (MRC) Fajara, The Gambia

View Trial Details

Completed

Safety and Tolerability of Low Dose Primaquine

NCT02434952

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +17 more
Locations: Ratanakiri Provincial Hospital Ratanakiri, Cambodia

View Trial Details

Completed

DSM265 Phase IIa Investigation Treating Plasmodium Falciparum or Vivax

NCT02123290

Conditions: Infections, Malaria, Malaria, Falciparum, +7 more
Locations: Clínica de la Asociación Civil Selva Amazónica Iquitos, Departamento de Loreto (Amazonía Peruana), Peru

View Trial Details

Completed

Molecular Surveillance of Artemisinin Resistance Malaria in Myanmar

NCT02792816

Conditions: Drug Resistance, Infections, Malaria, +6 more
Locations: Dr. Myat Phone Kyaw Yangon, Burma

View Trial Details

Completed

Dose Escalation, Randomized Controlled Trial to Evaluate the Safety, Immunogenicity and Efficacy of Intravenously Administered Attenuated Plasmodium Falciparum Sporozoite Vaccine (PfSPZ Vaccine) in Tanzanian Adults

NCT02132299

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: Bagamoyo Research and Training Center, Ifakara Health Institute, Kingani Estate, PO Box 74 Bagamoyo, Tanzania

View Trial Details

Completed

Controlled Human Malarial Infection by Intravenous Injection of Plasmodium Falciparum Sporozoites in Non-Immune Adults

NCT01624961

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Eberhard Karls University of Tübingen, Germany Tübingen, Germany

View Trial Details

Completed

Optimization of Controlled Human Malarial Infection by Injection of P. Falciparum Sporozoites in Non-Immune Adults

NCT01771848

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Centre d'Investigació del Medicament Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Barcelona, Spain

CRESIB, Hospital Clínic-Universitat de Barcelona Barcelona, Spain

View Trial Details

Malaria, Falciparum

Malaria, Falciparum trial results

Related conditions